金沙检测线路js95(中国)股份有限公司-Official website

You are about to leave Peijia Medical's official Chinese website.
You have just clicked on a link to another website. After clicking Continue, you may be taken to a website run by a third party. We are not responsible for the review and control of content outside Peijia Medical's official Chinese website, nor do we assume any responsibility for business transactions or matters conducted outside Peijia Medical's official Chinese website. The use of other websites is subject to the terms of use and privacy policies of those websites. Certain products or information found on other websites may not be approved for your region or country.
Cancel
Continue
Brief News on Innovation
Company News Brief News on Innovation
Brief News on Innovation
ONE-YEAR CLINICAL FOLLOW-UP RESULTS OF TaurusNXT® WERE RELEASED AT CHINA STRUCTURAL WEEK 2024
2024.10.18
ONE-YEAR CLINICAL FOLLOW-UP RESULTS OF TaurusNXT® WERE RELEASED AT CHINA S···

From October 9-16, 2024, China Structural Week 2024 was grandly held. TaurusNXT···
Peijia Medical Fluxcap® Balloon Guide Catheter Obtained NMPA Approval
2022.06.09
Peijia Medical Fluxcap® Balloon Guide Catheter Obtained NMPA Approval

On June 8, 2022, Peijia Medical received the approval from the National Medical ···
Peijia Medical Tethys AS® Aspiration Catheter and Fastunnel® Delivery Balloon Dilation Catheter Obtained NMPA Approval
2022.05.24
Peijia Medical Tethys AS® Aspiration Catheter and Fastunnel® Delivery Ballo···

Peijia Medical Tethys AS® Aspiration Catheter and Fastunnel® Delivery Balloon Di···
NMPA Approval for Registration Application of Syphonet®️ Stent Retriever
2022.02.17
NMPA Approval for Registration Application of Syphonet®️ Stent Retriever

On February 11, 2022, Peijia Medical Limited (the “Company”) received the approv···
The First Clinical Case using HighLife Transseptal Mitral Valve Replacement Technology was successfully carried out in Asia
2022.01.08
The First Clinical Case using HighLife Transseptal Mitral Valve Replacement···

On December 22, 2021, the first clinical case using HighLife transseptal mitral ···
Peijia Medical Announces First Patient Treatment in the Clinical Trial of its Innovative Non-implant
2021.11.01
Peijia Medical Announces First Patient Treatment in the Clinical Trial of i···

A major breakthrough in interventional therapy for heart valve disease and an in···
Peijia Medical Announces First Patient Implant in the Clinical Trial of its Third-Generation Transca
2021.09.14
Peijia Medical Announces First Patient Implant in the Clinical Trial of its···

Peijia Medical today announced the initiation of its multi-center clinical trial···
Peijia Medical Engages Professor Saibal Kar as Exclusive Consultant
2021.09.06
Peijia Medical Engages Professor Saibal Kar as Exclusive Consultant

Peijia Medical Engages Professor Saibal Kar as Exclusive ConsultantTo Advise the···
TaurusOne® Valve clinical outcome published in EuroIntervention
2021.08.09
TaurusOne® Valve clinical outcome published in EuroIntervention

TaurusOne® Valve clinical outcome published in EuroIntervention The fi···
With the second-generation transcatheter aortic valve replacement system approved for marketing, Pei
2021.06.26
With the second-generation transcatheter aortic valve replacement system ap···

With the second-generation transcatheter aortic valve replacement system approve···
Peijia Medical’s Jasper® SS Detachable Coil Receives NMPA Approval for Commercialization
2021.06.25
Peijia Medical’s Jasper® SS Detachable Coil Receives NMPA Approval for Comm···

[June 24, SUZHOU] On June 15, 2021, Jasper® SS—a new detachable coil indepe···
Peijia Medical’s TaurusOne® Transcatheter Aortic Valve Replacement System Approved for Commercializa
2021.04.26
Peijia Medical’s TaurusOne® Transcatheter Aortic Valve Replacement System A···

A new interventional solution from China for structural heart disease is about t···
Home < ···34567 > Last
Top
XML 地图